Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.68 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | NCF1 | P14598 | 1/20 | 0.61 |
| ▸ | DRD4 | P21917 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CYP2A13 | Q16696 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.57 |
| ▸ | MC4R | P32245 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL948372 | 1.00 | SIGMAR1 (0.68) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| SCHEMBL18065638 | 1.00 | SIGMAR1 (0.68) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| SCHEMBL102338 | 0.98 | SIGMAR1 (0.71) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| SCHEMBL6200777 | 0.98 | SIGMAR1 (0.71) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| Water SCHEMBL1702298 | 0.96 | SIGMAR1 (0.68) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| Hydrochloric Acid SCHEMBL6261135 | 0.96 | SIGMAR1 (0.68) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| SCHEMBL28158277 | 0.96 | SIGMAR1 (0.68) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| SCHEMBL6384833 | 0.94 | HRH3 (0.61) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| SCHEMBL18309364 | 0.94 | HRH3 (0.61) | SIGMAR1HRH3ALDH1A1HTTKDM4E | |
| SCHEMBL24200050 | 0.93 | HRH3 (0.62) | SIGMAR1HRH3ALDH1A1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110873-A1 | SENSOR FOR DETECTING TRACE IONS AND METHOD THEREOF | VULCAN PHOTONICS SDN. BHD. (MY) | 2025-05-30 | — | — | WO | claimed |
| US-20250093308-A1 | MILLIFLUIDIC CHROMATOGRAPHY PLATE | VULCAN PHOTONICS SDN. BHD. (MY) | 2025-03-20 | — | — | US | claimed |
| US-20250082793-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF MAKING THE SAME | JANSSEN BIOTECH, INC. | 2025-03-13 | — | — | US | claimed |
| CN-119234151-A | Millifluidic chromatography plate | 伏尔甘光电私人有限公司 | 2024-12-31 | — | — | CN | claimed |
| EP-4476542-A1 | MILLIFLUIDIC CHROMATOGRAPHY PLATE | Vulcan Photonics SDN. BHD. (MY) | 2024-12-18 | — | — | EP | claimed |
| WO-2024248601-A1 | METHOD FOR PREPARING MODIFIED LIGANDS FOR DETECTING IONS | VULCAN PHOTONICS SDN. BHD. (MY) | 2024-12-05 | — | — | WO | claimed |
| WO-2024225888-A1 | MILLIFLUIDIC CHROMATOGRAPHY PLATE | VULCAN PHOTONICS SDN. BHD. (MY) | 2024-10-31 | — | — | WO | claimed |
| EP-4430040-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF MAKING THE SAME | Janssen Biotech, Inc. (US) | 2024-09-18 | — | — | EP | claimed |
| CN-118515556-A | Preparation method of caprylic-capric glyceride | 万华化学集团股份有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-118201925-A | Macrocyclic compounds and methods of making the same | 詹森生物科技公司 | 2024-06-14 | — | — | CN | claimed |
| EP-1858990-A1 | INK COMPOSITION FOR CONTINUOUS DEFLECTED INK JET PRINTING | IMAJE S.A. (FR) | 2007-11-28 | — | — | EP | claimed |
| WO-2006097502-A1 | INK COMPOSITION FOR CONTINUOUS DEFLECTED INK JET PRINTING | IMAJE S.A. (FR) | 2006-09-21 | — | — | WO | claimed |
| US-6797745-B1 | Hot melt inks containing styrene or terpene polymers | XEROX CORPORATION | 2004-09-28 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-5702804-A | Recording sheets | XEROX CORPORATION (US) | 1997-12-30 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250082793-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF MAKING THE SAME | PAICS, CD47, FURIN | SIGMAR1 4561/4885HRH3 2500/4885ALDH1A1 2835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.